5th Berlin Conference on IP in Life Sciences
"5th Berlin Conference on IP in Life Sciences: Antibodies & Beyond - Modern Immune Therapies"
| Wann |
17.02.2012 von 09:00 bis 18:00 |
|---|---|
| Wo | Berlin |
| Name | Philip Zurdel |
| Kontakttelefon | 030-264921-0 |
| Termin übernehmen |
vCal
iCal
|
With the "5th Berlin Conference on IP in Life Sciences: Antibodies & Beyond - Modern Immune Therapies", BIOCOM is once again organising the first highlight of the coming year's conference program.
The conference will be taking place on 17 February 2012 in the Embassy of Switzerland, Berlin. This BIOCOM Event is a unique opportunity to gain insight into the strategies of pharma and biotech companies.
Leading experts in the field of immune therapies will share their knowledge on how to successfully develop and market new concepts.
Representatives from biotech and pharmaceutical companies, researchers, business developers, clinical trial and marketing experts, as well as investors, advisers and patent lawyers can’t afford to miss this high-level event. In addition, there will be numerous opportunities to build up your networking contacts.
You can find further information at http://www.biocom.de/events/IP .
BIOCOM AG
Luetzowstr. 33-36, 10785 Berlin, Germany Tel +49-30-264921-0 | Fax +49-30-264921-11
Sitz Berlin | AG Berlin-Charlottenburg | HRB 68816
Vorstand: Dipl.-Biol. Andreas Mietzsch (Vors.), Michael Kuhrt
Aufsichtsratsvorsitzender: Dr. Andreas Immelmann
http://www.biocom.de
http://www.transkript.de
http://www.eurobiotechnews.eu
http://www.laborwelt.de
